Recombinant protein vaccines use proteins from the pathogen to provoke an immune response. These proteins are produced using recombinant DNA technology, where the protein-coding gene from the pathogen is inserted into a production system like yeast or mammalian cells. An example is the Hepatitis B vaccine. These vaccines are highly purified and generally show a good safety profile, making them suitable for large-scale immunization programs.
